tiprankstipranks
Trending News
More News >
XBiotech (XBIT)
NASDAQ:XBIT
US Market

XBiotech (XBIT) Income Statement

Compare
340 Followers

XBiotech Income Statement

Last quarter (Q4 2025), XBiotech's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, XBiotech's net income was $-26.89M. See XBiotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 4.01M$ 18.39M
Gross Profit
$ -1.69M$ 0.00$ 0.00$ 3.36M$ 12.57M
Operating Expenses
$ 54.00M$ 42.47M$ 37.51M$ 37.85M$ 37.66M
Depreciation and Amortization
$ 1.69M$ 1.75M$ 1.74M$ 2.61M$ 2.65M
EBITDA
$ -54.00M$ -36.01M$ -22.57M$ -31.88M$ -22.43M
Operating Income
$ -55.69M$ -42.47M$ -37.51M$ -34.49M$ -25.08M
Other Income/Expenses
$ 10.38M$ 3.91M$ 13.20M$ 902.00K$ -376.00K
Pretax Income
$ -45.30M$ -38.56M$ -24.31M$ -33.59M$ -25.46M
Net Income
$ -45.54M$ -38.53M$ -24.56M$ -32.90M$ -17.41M
Per Share Metrics
Basic EPS
$ -1.49$ -1.26$ -0.81$ -1.08$ -0.58
Diluted EPS
$ -1.49$ -1.26$ -0.81$ -1.08$ -0.58
Weighted Average Shares Outstanding
30.49M 30.46M 30.32M 30.44M 30.04M
Weighted Average Shares Outstanding (Diluted)
30.49M 30.46M 30.44M 30.44M 30.04M
Currency in USD

XBiotech Earnings and Revenue History